2nd Quarter - Report
TIBER CREEK GROUP for AMGEN INC
Firm
Client
Income
$80,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Stopping the Phrma Industry from Keeping Drugs Expensive Act (SPIKE Act)- S.474. Issues relating to Part D pricing reform. Issues relating to Part B pricing reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JAMES HEIMBACH | — |
| JONATHON JONES | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.